Disease | Target Count | P-value |
---|---|---|
Breast cancer | 3578 | 5.8e-33 |
non-small cell lung cancer | 2890 | 7.6e-16 |
lung adenocarcinoma | 2716 | 2.8e-14 |
lung carcinoma | 2843 | 1.2e-13 |
ovarian cancer | 8520 | 1.6e-10 |
malignant mesothelioma | 3232 | 5.3e-07 |
ductal carcinoma in situ | 1745 | 1.3e-04 |
invasive ductal carcinoma | 2951 | 1.3e-04 |
osteosarcoma | 7950 | 2.9e-04 |
adrenocortical carcinoma | 1428 | 5.7e-04 |
cystic fibrosis | 1696 | 1.6e-03 |
psoriasis | 6694 | 2.0e-03 |
ulcerative colitis | 1819 | 2.0e-03 |
cutaneous lupus erythematosus | 1057 | 2.7e-03 |
nephrosclerosis | 333 | 2.9e-03 |
pituitary cancer | 1972 | 4.7e-03 |
esophageal adenocarcinoma | 737 | 1.8e-02 |
lung cancer | 4740 | 3.2e-02 |
Disease | Target Count | Z-score | Confidence |
---|---|---|---|
Crohn's disease | 321 | 0.0 | 3.0 |
Disease | log2 FC | p |
---|---|---|
adrenocortical carcinoma | -3.099 | 5.7e-04 |
Breast cancer | -2.000 | 5.8e-33 |
cutaneous lupus erythematosus | -1.400 | 2.7e-03 |
cystic fibrosis | -1.200 | 1.6e-03 |
ductal carcinoma in situ | -1.500 | 1.3e-04 |
esophageal adenocarcinoma | 1.400 | 1.8e-02 |
invasive ductal carcinoma | -2.000 | 1.3e-04 |
lung adenocarcinoma | -1.400 | 2.8e-14 |
lung cancer | -1.100 | 3.2e-02 |
lung carcinoma | -1.200 | 1.2e-13 |
malignant mesothelioma | -2.500 | 5.3e-07 |
nephrosclerosis | -1.712 | 2.9e-03 |
non-small cell lung cancer | -1.296 | 7.6e-16 |
osteosarcoma | -2.579 | 2.9e-04 |
ovarian cancer | -2.700 | 1.6e-10 |
pituitary cancer | 1.800 | 4.7e-03 |
psoriasis | -1.600 | 2.0e-03 |
ulcerative colitis | -1.300 | 2.0e-03 |
MPLKLRGKKKAKSKETAGLVEGEPTGAGGGSLSASRAPARRLVFHAQLAHGSATGRVEGFSSIQELYAQI 1 - 70 AGAFEISPSEILYCTLNTPKIDMERLLGGQLGLEDFIFAHVKGIEKEVNVYKSEDSLGLTITDNGVGYAF 71 - 140 IKRIKDGGVIDSVKTICVGDHIESINGENIVGWRHYDVAKKLKELKKEELFTMKLIEPKKAFEIELRSKA 141 - 210 GKSSGEKIGCGRATLRLRSKGPATVEEMPSETKAKAIEKIDDVLELYMGIRDIDLATTMFEAGKDKVNPD 211 - 280 EFAVALDETLGDFAFPDEFVFDVWGVIGDAKRRGL 281 - 315 //